Home › Funds › Holocene Advisors, LP › CVS

Holocene Advisors, LP position in CVS

CVS HEALTH CORP · Consumer Staples

Holocene Advisors, LP reported holding 3,001,684 shares of CVS (CVS HEALTH CORP) in its Q2 2026 13F filing — a position valued at US$310.5M, representing 0.74% of its reported portfolio and ranking #24 among its reported holdings. Holocene Advisors, LP has disclosed CVS holdings in 9 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)3.00M sh
Reported value held$310.52M
Portfolio Weight0.74%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Holocene Advisors, LP's CVS position evolved

Holocene Advisors, LP first disclosed a stake in CVS in Q3 2023 at 753,390 shares (US$52.6M). The position peaked in Q1 2025 at 5,928,174 shares, worth US$401.6M. Across 9 filings, Holocene Advisors, LP increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 3,001,684 shares valued at US$310.5M — an increase of 2,301,684 shares quarter over quarter.. Notable position changes include a 125% increase in Q1 2025 (shares rose 3% over the following quarter), a 138% increase in Q4 2025 (shares fell 9% over the following quarter), a 329% increase in Q2 2026 (shares fell 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 753.39K $52.60M New
Q2 2024 2.74M $161.75M New
Q4 2024 2.64M $118.32M New
Q1 2025 5.93M $401.63M Add
Q2 2025 2.37M $163.75M Reduce
Q3 2025 1.67M $125.77M Reduce
Q4 2025 3.97M $314.96M Add
Q1 2026 700.00K $50.27M Reduce
Q2 2026 3.00M $310.52M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CVS and 13F data

CVS (CVS HEALTH CORP) is a Consumer Staples company. 39 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$7.75B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CVS

All CVS fund holders →

FAQ

How long has Holocene Advisors, LP held CVS?

Holocene Advisors, LP has disclosed CVS holdings in 9 of the last 12 reported quarters, going back to Q3 2023.

What is Holocene Advisors, LP's current position in CVS?

As of Q2 2026, Holocene Advisors, LP holds 3.00M shares of CVS (CVS HEALTH CORP), valued at $310.52M, representing 0.74% of its reported portfolio and ranking #24.

Has Holocene Advisors, LP been buying or selling CVS?

In the latest 13F filing (Q2 2026), Holocene Advisors, LP increased its position in CVS. The position peaked in Q1 2025 at 5.93M shares.

Which other funds hold CVS?

Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.